Holcim stock: Q3 beat lifts 2026 EBIT outlook to 10%-12%
Published on 11/03/2026 at 17:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSHolcim raises outlook after strong quarter
- Third-quarter recurring EBIT rose 16.8 percent in Swiss francs and sales increased 15.5 percent.
- The Fermacell deal expands Holcim's walling, flooring and fire-protection portfolio, with closing expected in the first half of 2027.
- Management expects further margin expansion and free cash flow of about CHF 2 billion for 2026.
Holcim raised its full-year 2026 recurring EBIT outlook on October 23 after a stronger third quarter. The company's Q3 2026 results release shows faster profit growth, wider margins and a new acquisition milestone.
Holcim stock traded at 77.33 euros on Lang & Schwarz at 17:39 CET on Tuesday, November 3, 2026. For the latest quote, see the real-time quote of Holcim stock.
Profit growth strengthens the outlook
Recurring EBIT rose 16.8 percent in Swiss francs to CHF 976 million in the third quarter, while net sales increased 15.5 percent to CHF 4.662 billion. The recurring EBIT margin widened to 20.9 percent from 20.7 percent a year earlier.
For the first nine months, organic net sales growth reached 5.2 percent and organic recurring EBIT growth reached 11.8 percent. Recurring EBIT totaled CHF 2.414 billion, while the nine-month margin rose 10 basis points to 19.2 percent.
Fermacell adds a new growth leg
Holcim's binding agreement to acquire Fermacell broadens its European walling, flooring and fire-protection portfolio. The company said Fermacell has projected 2026 net sales of about EUR 430 million, with closing expected in the first half of 2027 subject to customary conditions and regulatory clearances.
Management expects organic net sales growth of about 5 percent in 2026, further recurring EBIT margin expansion and free cash flow of about CHF 2 billion. Holcim also targets growth of more than 20 percent in recycled construction and demolition materials.
Execution remains the investor focus
The results show operating leverage, with organic recurring EBIT growth outpacing organic sales growth during the first nine months. Investors will now focus on demand, cost discipline and the completion of the Fermacell transaction as Holcim works toward its upgraded full-year targets.
The broader Swiss market backdrop is covered in current SMI market reports.
More news and analyses on Holcim stock provide further context on the company's earnings outlook and share performance.
Holcim stock at a glance
- Company: Holcim Ltd
- ISIN: CH0012214059
- Ticker: HOLN
- Home exchange: SIX Swiss Exchange
- Lang & Schwarz quote: 77.33 euros on November 3, 2026 at 17:39 CET
- 2026 recurring EBIT outlook: 10 percent to 12 percent organic growth
